Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Citations to this article

Cardiac fibrosis in mice with hypertrophic cardiomyopathy is mediated by non-myocyte proliferation and requires Tgf-β
Polakit Teekakirikul, … , Christine E. Seidman, Jonathan G. Seidman
Polakit Teekakirikul, … , Christine E. Seidman, Jonathan G. Seidman
Published September 1, 2010
Citation Information: J Clin Invest. 2010;120(10):3520-3529. https://doi.org/10.1172/JCI42028.
View: Text | PDF
Research Article Cardiology Article has an altmetric score of 12

Cardiac fibrosis in mice with hypertrophic cardiomyopathy is mediated by non-myocyte proliferation and requires Tgf-β

  • Text
  • PDF
Abstract

Mutations in sarcomere protein genes can cause hypertrophic cardiomyopathy (HCM), a disorder characterized by myocyte enlargement, fibrosis, and impaired ventricular relaxation. Here, we demonstrate that sarcomere protein gene mutations activate proliferative and profibrotic signals in non-myocyte cells to produce pathologic remodeling in HCM. Gene expression analyses of non-myocyte cells isolated from HCM mouse hearts showed increased levels of RNAs encoding cell-cycle proteins, Tgf-β, periostin, and other profibrotic proteins. Markedly increased BrdU labeling, Ki67 antigen expression, and periostin immunohistochemistry in the fibrotic regions of HCM hearts confirmed the transcriptional profiling data. Genetic ablation of periostin in HCM mice reduced but did not extinguish non-myocyte proliferation and fibrosis. In contrast, administration of Tgf-β–neutralizing antibodies abrogated non-myocyte proliferation and fibrosis. Chronic administration of the angiotensin II type 1 receptor antagonist losartan to mutation-positive, hypertrophy-negative (prehypertrophic) mice prevented the emergence of hypertrophy, non-myocyte proliferation, and fibrosis. Losartan treatment did not reverse pathologic remodeling of established HCM but did reduce non-myocyte proliferation. These data define non-myocyte activation of Tgf-β signaling as a pivotal mechanism for increased fibrosis in HCM and a potentially important factor contributing to diastolic dysfunction and heart failure. Preemptive pharmacologic inhibition of Tgf-β signals warrants study in human patients with sarcomere gene mutations.

Authors

Polakit Teekakirikul, Seda Eminaga, Okan Toka, Ronny Alcalai, Libin Wang, Hiroko Wakimoto, Matthew Nayor, Tetsuo Konno, Joshua M. Gorham, Cordula M. Wolf, Jae B. Kim, Joachim P. Schmitt, Jefferey D. Molkentin, Russell A. Norris, Andrew M. Tager, Stanley R. Hoffman, Roger R. Markwald, Christine E. Seidman, Jonathan G. Seidman

×

Total citations by year

Year: 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 Total
Citations: 6 16 20 20 21 13 18 17 21 20 13 27 19 16 16 1 1 265
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal. Not all publishers participate in CrossRef, so this information is not comprehensive. Additionally, data may not reflect the most current citations to this article, and the data may differ from citation information available from other sources (for example, Google Scholar, Web of Science, and Scopus).

Citations to this article (265)

Title and authors Publication Year
Targeting E prostanoid receptor EP4 to treat cardiac fibrosis
Hu Xu, Xiuhui Mao, Yali Wang, Chunhua Zhu, Bo Liang, Yihang Zhao, Mengfei Zhou, Lan Ye, Mengting Hong, Huishu Shao, Yashuo Wang, Haonan Li, Yinghui Qi, Yongliang Yang, Youfei Guan, Xiaoyan Zhang
Advanced science (Weinheim, Baden-Wurttemberg, Germany) 2025
Contribution of hypoxia-inducible factor 1alpha to pathogenesis of sarcomeric hypertrophic cardiomyopathy
Raj Murthi S, Petry A, Shashikadze B, Stöckl JB, Schmid M, Santamaria G, Klingel K, Kračun D, Chen X, Bauer S, Schmitt JP, Flenkenthaler F, Gorham J, Toepfer CN, Potěšil D, Hruška P, Zdráhal Z, Mayer Z, Klop M, Lehmann L, Qin Y, Papanakli L, Spielmann N, Moretti A, Fröhlich T, Ewert P, Holdenrieder S, Seidman JG, Seidman CE, Görlach A, Wolf CM
Scientific Reports 2025
The Role of Signalling Pathways in Myocardial Fibrosis in Hypertrophic Cardiomyopathy
Skórka P, Piotrowski J, Bakinowska E, Kiełbowski K, Pawlik A
Reviews in Cardiovascular Medicine 2025
Valsartan and Cardiac Remodeling in Early-Stage Hypertrophic Cardiomyopathy: The VANISH Randomized Clinical Trial Cardiac Magnetic Resonance Substudy
Ostrominski JW, Claggett BL, Jerosch-Herold M, Raja AA, Day SM, Russell MW, Zahka K, Pereira AC, Colan SD, Murphy AM, Canter C, Bach RG, Wheeler MT, Rossano JW, Owens AT, Mestroni L, Taylor MR, Patel AR, Wilmot I, Soslow JH, Becker JR, Lakdawala NK, Bundgaard H, Vargas JD, Ho CY
JAMA Cardiology 2025
Cardiac Fibroblasts: Helping or Hurting
Shameem M, Olson SL, Marron Fernandez de Velasco E, Kumar A, Singh BN
Genes 2025
A case report of MYH7 mutation-induced restrictive cardiomyopathy
Zhang S, Zhao W
European Heart Journal. Case Reports 2025
The Role of Pro-Inflammatory Cytokines in the Pathogenesis of Cardiovascular Disease
Zhang H, Dhalla NS
International journal of molecular sciences 2024
Contemporary review on pediatric hypertrophic cardiomyopathy: insights into detection and management
Shafqat A, Shaik A, Koritala S, Mushtaq A, Sabbah BN, Nahid Elshaer A, Baqal O
Frontiers in Cardiovascular Medicine 2024
TGF-β signaling in health, disease, and therapeutics.
Deng Z, Fan T, Xiao C, Tian H, Zheng Y, Li C, He J
Signal Transduction and Targeted Therapy 2024
Empagliflozin and liraglutide ameliorate HFpEF in mice via augmenting the Erbb4 signaling pathway.
Ni XY, Feng XJ, Wang ZH, Zhang Y, Little PJ, Cao Y, Xu SW, Tang LQ, Weng JP
Acta Pharmacologica Sinica 2024
Substrate mechanics unveil early structural and functional pathology in iPSC micro-tissue models of hypertrophic cardiomyopathy
Guo J, Jiang H, Schuftan D, Moreno JD, Ramahdita G, Aryan L, Bhagavan D, Silva J, Huebsch N
iScience 2024
Single-nucleus RNA/ATAC-seq in early-stage HCM models predicts SWI/SNF-activation in mutant-myocytes, and allele-specific differences in fibroblasts
Thottakara T, Padmanabhan A, Tanriverdi T, Thambidurai T, Diaz-RG JA, Amonkar SR, Olgin JE, Long CS, Roselle Abraham M
2024
The Phenotypic Spectrum of Subclinical Sarcomere-related Hypertrophic Cardiomyopathy and Transition to Overt Disease
Topriceanu CC, Moon JC, Raja AA, Captur G, Ho CY
Circulation. Genomic and precision medicine 2024
Genetic testing and human leukocyte antigen in patients with hypertrophic cardiomyopathy and connective tissue diseases.
Hiraya D, Murakoshi N, Igarashi M, Xu D, Ishizu T
Frontiers in genetics 2024
Engineered model of heart tissue repair for exploring fibrotic processes and therapeutic interventions.
Yang P, Zhu L, Wang S, Gong J, Selvaraj JN, Ye L, Chen H, Zhang Y, Wang G, Song W, Li Z, Cai L, Zhang H, Zhang D
Nature communications 2024
A New Ex Vivo Model to Study Cardiac Fibrosis in Whole Mouse Hearts
Kruithof BP, Mousavi Gourabi B, van de Merbel AF, DeRuiter MC, Goumans MJ
JACC: Basic to Translational Science 2024
Hypertrophic cardiomyopathy-associated mutations drive stromal activation via EGFR-mediated paracrine signaling.
Ewoldt JK, Wang MC, McLellan MA, Cloonan PE, Chopra A, Gorham J, Li L, DeLaughter DM, Gao X, Lee JH, Willcox JAL, Layton O, Luu RJ, Toepfer CN, Eyckmans J, Seidman CE, Seidman JG, Chen CS
Science advances 2024
The clinical efficacy of cGMP-specific sildenafil on mitochondrial biogenesis induction and renal damage in cats with acute on chronic kidney disease.
Maden M, Ider M, Or ME, Dokuzeylül B, Gülersoy E, Kılıçkaya MC, Bilgiç B, Durgut MK, İzmirli S, Iyigün SS, Telci DZ, Naseri A
BMC veterinary research 2024
Integrative analysis of transcriptome, DNA methylome, and chromatin accessibility reveals candidate therapeutic targets in hypertrophic cardiomyopathy.
Gao J, Liu M, Lu M, Zheng Y, Wang Y, Yang J, Xue X, Liu Y, Tang F, Wang S, Song L, Wen L, Wang J
Protein & cell 2024
The Macrophage–Fibroblast Dipole in the Context of Cardiac Repair and Fibrosis
Psarras S
Biomolecules 2024
Obstructive hypertrophic cardiomyopathy: from genetic insights to a multimodal therapeutic approach with mavacamten, aficamten, and beyond
Sarwer K, Lashari S, Rafaqat N, Maher, Raheem A, Rehman MU, Abbas SM
The Egyptian Heart Journal 2024
Comprehensive Proteomic Profiling of Human Myocardium Reveals Signaling Pathways Dysregulated in Hypertrophic Cardiomyopathy
Lumish HS, Sherrid MV, Janssen PM, Ferrari G, Hasegawa K, Castillero E, Adlestein E, Swistel DG, Topkara VK, Maurer MS, Reilly MP, Shimada YJ
Journal of the American College of Cardiology 2024
PANoptosis is a prominent feature of desmoplakin cardiomyopathy
Olcum M, Rouhi L, Fan S, Gonzales MM, Jeong HH, Zhao Z, Gurha P, Marian AJ
2023
Efficient in vivo genome editing prevents hypertrophic cardiomyopathy in mice
Reichart D, Newby GA, Wakimoto H, Lun M, Gorham JM, Curran JJ, Raguram A, DeLaughter DM, Conner DA, Marsiglia JD, Kohli S, Chmatal L, Page DC, Zabaleta N, Vandenberghe L, Liu DR, Seidman JG, Seidman C
Nature Medicine 2023
Cardiac Resynchronization Therapy and Hypertrophic Cardiomyopathy: A Comprehensive Review
Radu AD, Cojocaru C, Onciul S, Scarlatescu A, Zlibut A, Nastasa A, Dorobantu M
Biomedicines 2023
Base editing correction of hypertrophic cardiomyopathy in human cardiomyocytes and humanized mice.
Chai AC, Cui M, Chemello F, Li H, Chen K, Tan W, Atmanli A, McAnally JR, Zhang Y, Xu L, Liu N, Bassel-Duby R, Olson EN
Nature Medicine 2023
Narrative review of pediatric heart failure in the age of precision medicine
Valikodath N, Godown J, Sheybani A
Translational Pediatrics 2023
MYH7 in cardiomyopathy and skeletal muscle myopathy.
Gao Y, Peng L, Zhao C
Molecular and Cellular Biochemistry 2023
Transforming Growth Factor-β Analysis of the VANISH Trial Cohort.
Kim Y, Mastali M, Van Eyk JE, Orav EJ, Vissing CR, Day SM, Axelsson Raja A, Russell MW, Zahka K, Lever HM, Pereira AC, Murphy AM, Canter C, Bach RG, Wheeler MT, Rossano JW, Owens AT, Bundgaard H, Benson L, Mestroni L, Taylor MRG, Patel AR, Wilmot I, Thrush P, Soslow JH, Becker JR, Seidman CE, Ho CY
Circulation. Heart failure 2023
Stage-specific therapy for hypertrophic cardiomyopathy
Argirò A, Zampieri M, Marchi A, Cappelli F, Del Franco A, Mazzoni C, Cecchi F, Olivotto I
2023
Trends in worldwide research on cardiac fibrosis over the period 1989–2022: a bibliometric study
Mao Y, Fu Q, Su F, Zhang W, Zhang Z, Zhou Y, Yang C
Frontiers in Cardiovascular Medicine 2023
Mechanisms and prognostic impact of myocardial ischaemia in hypertrophic cardiomyopathy.
Coleman JA, Ashkir Z, Raman B, Bueno-Orovio A
The International Journal of Cardiovascular Imaging 2023
p53 Regulates the Extent of Fibroblast Proliferation and Fibrosis in Left Ventricle Pressure Overload.
Liu X, Burke RM, Lighthouse JK, Baker CD, Dirkx RA Jr, Kang B, Chakraborty Y, Mickelsen DM, Twardowski JJ, Mello SS, Ashton JM, Small EM
Circulation research 2023
Chronic activation of human cardiac fibroblasts in vitro attenuates the reversibility of the myofibroblast phenotype.
Hall C, Law JP, Reyat JS, Cumberland MJ, Hang S, Vo NTN, Raniga K, Weston CJ, O'Shea C, Townend JN, Gehmlich K, Ferro CJ, Denning C, Pavlovic D
Scientific Reports 2023
Prognostic and Safety Implications of Renin-Angiotensin-Aldosterone System Inhibitors in Hypertrophic Cardiomyopathy: A Real-World Observation Over 2,000 Patients
Park CS, Rhee TM, Lee HJ, Yoon YE, Park JB, Lee SP, Kim YJ, Cho GY, Hwang IC, Kim HK
Korean Circulation Journal 2023
Myocardial Fibrosis in Hypertrophic Cardiomyopathy: A Perspective from Fibroblasts
Schlittler M, Pramstaller PP, Rossini A, De Bortoli M
International journal of molecular sciences 2023
The role of periostin in cardiac fibrosis.
Qiao B, Liu X, Wang B, Wei S
Heart Failure Reviews 2023
Periostin is overexpressed, correlated with fibrosis and differs among grades of cardiomyocyte hypertrophy in myectomy tissue of patients with hypertrophic cardiomyopathy
Ioakeimidis NS, Pitsis A, Zegkos T, Ntelios D, Kelpis T, Papamitsou T, Parcharidou D, Gossios T, Efthimiadis G, Meditskou S
PloS one 2023
MDM2 Regulation of HIF Signaling Causes Microvascular Dysfunction in Hypertrophic Cardiomyopathy
Shridhar P, Glennon MS, Pal S, Waldron CJ, Chetkof EJ, Basak P, Clavere NG, Banerjee D, Gingras S, Becker JR
Circulation 2023
Integrating mechanical cues with engineered platforms to explore cardiopulmonary development and disease
Ahmed DW, Eiken MK, DePalma SJ, Helms AS, Zemans RL, Spence JR, Baker BM, Loebel C
iScience 2023
Inhibition of miR-199a-3p in a murine hypertrophic cardiomyopathy (HCM) model attenuates fibrotic remodeling
Zalivina I, Barwari T, Yin X, Langley SR, Barallobre-Barreiro J, Wakimoto H, Zampetaki A, Mayr M, Avkiran M, Eminaga S
2023
Transflammation in Tissue Regeneration and Response to Injury: How cell-autonomous inflammatory signaling mediates cell plasticity
Cooke JP, Lai L
Advanced Drug Delivery Reviews 2023
FAM114A1 Influences Cardiac Pathological Remodeling by Regulating Angiotensin II Signaling
Kadiam C Venkata Subbaiah, Jiangbin Wu, W.H. Wilson Tang, Peng Yao
JCI Insight 2022
Transforming growth factor-β in myocardial disease
NG Frangogiannis
Nature Reviews Cardiology 2022
Pharmacological Management of Hypertrophic Cardiomyopathy: From Bench to Bedside
Palandri C, Santini L, Argirò A, Margara F, Doste R, Bueno-Orovio A, Olivotto I, Coppini R
Drugs 2022
Copper chelation in patients with hypertrophic cardiomyopathy
Reid A, Miller C, Farrant JP, Polturi R, Clark D, Ray S, Cooper G, Schmitt M
Open Heart 2022
Exploring the Communal Pathogenesis, Ferroptosis Mechanism, and Potential Therapeutic Targets of Dilated Cardiomyopathy and Hypertrophic Cardiomyopathy via a Microarray Data Analysis
Wang Z, Xia Q, Su W, Cao M, Sun Y, Zhang M, Chen W, Jiang T
Frontiers in Cardiovascular Medicine 2022
Postnatal Deletion of Bmal1 in Cardiomyocyte Promotes Pressure Overload Induced Cardiac Remodeling in Mice.
Liang Q, Xu H, Liu M, Qian L, Yan J, Yang G, Chen L
Journal of the American Heart Association 2022
ChGn-2 Plays a Cardioprotective Role in Heart Failure Caused by Acute Pressure Overload.
Haryono A, Ikeda K, Nugroho DB, Ogata T, Tsuji Y, Matoba S, Moriwaki K, Kitagawa H, Igarashi M, Hirata KI, Emoto N
Journal of the American Heart Association 2022
Ablation of lysophosphatidic acid receptor 1 attenuates hypertrophic cardiomyopathy in a mouse model.
Axelsson Raja A, Wakimoto H, DeLaughter DM, Reichart D, Gorham J, Conner DA, Lun M, Probst CK, Sakai N, Knipe RS, Montesi SB, Shea B, Adam LP, Leinwand LA, Wan W, Choi ES, Lindberg EL, Patone G, Noseda M, Hübner N, Seidman CE, Tager AM, Seidman JG, Ho CY
Proceedings of the National Academy of Sciences 2022
CDC-like kinase 4 deficiency contributes to pathological cardiac hypertrophy by modulating NEXN phosphorylation.
Huang J, Wang L, Shen Y, Zhang S, Zhou Y, Du J, Ma X, Liu Y, Liang D, Shi D, Ma H, Li L, Zhang Q, Chen YH
Nature Communications 2022
Transcriptional bursts and heterogeneity among cardiomyocytes in hypertrophic cardiomyopathy.
Burkart V, Kowalski K, Aldag-Niebling D, Beck J, Frick DA, Holler T, Radocaj A, Piep B, Zeug A, Hilfiker-Kleiner D, Dos Remedios CG, van der Velden J, Montag J, Kraft T
Frontiers in Cardiovascular Medicine 2022
Hypertrophic cardiomyopathy: Mutations to mechanisms to therapies
Kawana M, Spudich JA, Ruppel KM
Frontiers in physiology 2022
Maternal perfluorooctane sulfonic acid exposure during rat pregnancy causes hypersensitivity to angiotensin II and attenuation of endothelium-dependent vasodilation in the uterine arteries †.
Dangudubiyyam SV, Mishra JS, Song R, Kumar S
Biology of reproduction 2022
Contemporary Therapies and Future Directions in the Management of Hypertrophic Cardiomyopathy.
Packard E, de Feria A, Peshin S, Reza N, Owens AT
Cardiology and Therapy 2022
Defects in the Proteome and Metabolome in Human Hypertrophic Cardiomyopathy
Previs MJ, O\u2019Leary TS, Morley MP, Palmer B, LeWinter M, Yob J, Pagani FD, Petucci C, Kim MS, Margulies KB, Arany Z, Kelly DP, Day SM
Circulation. Heart failure 2022
Proteomics profiling reveals a distinct high-risk molecular subtype of hypertrophic cardiomyopathy
Liang LW, Raita Y, Hasegawa K, Fifer MA, Maurer MS, Reilly MP, Shimada YJ
Heart (British Cardiac Society) 2022
Defining the timeline of periostin upregulation in cardiac fibrosis following acute myocardial infarction in mice.
Gil H, Goldshtein M, Etzion S, Elyagon S, Hadad U, Etzion Y, Cohen S
Scientific Reports 2022
What Causes Hypertrophic Cardiomyopathy?
Maron BA, Wang RS, Carnethon MR, Rowin EJ, Loscalzo J, Maron BJ, Maron MS
The American Journal of Cardiology 2022
Transcriptional regulation of cardiac fibroblast phenotypic plasticity
Burgos Villar KN, Liu X, Small EM
Current Opinion in Physiology 2022
Lumican accumulates with fibrillar collagen in fibrosis in hypertrophic cardiomyopathy
Rixon C, Andreassen K, Shen X, Erusappan PM, Almaas VM, Palmero S, Dahl CP, Ueland T, Sjaastad I, Louch WE, Stokke MK, Tønnessen T, Christensen G, Lunde IG
ESC Heart Failure 2022
Fibroblasts orchestrate cellular crosstalk in the heart through the ECM
Bowers SL, Meng Q, Molkentin JD
2022
Individualized interactomes for network-based precision medicine in hypertrophic cardiomyopathy with implications for other clinical pathophenotypes
BA Maron, RS Wang, S Shevtsov, SG Drakos, E Arons, O Wever-Pinzon, GS Huggins, AO Samokhin, WM Oldham, Y Aguib, MH Yacoub, EJ Rowin, BJ Maron, MS Maron, J Loscalzo
Nature Communications 2021
LAMP2 Cardiomyopathy: Consequences of Impaired Autophagy in the Heart
R Alcalai, M Arad, H Wakimoto, D Yadin, J Gorham, L Wang, E Burns, BJ Maron, WC Roberts, T Konno, DA Conner, AR PerezAtayde, JG Seidman, CE Seidman
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease 2021
Shared Molecular Mechanisms of Hypertrophic Cardiomyopathy and Its Clinical Presentations: Automated Molecular Mechanisms Extraction Approach
M Glavaški, L Velicki
Life Sciences 2021
Valsartan in early-stage hypertrophic cardiomyopathy: a randomized phase 2 trial
CY Ho, SM Day, A Axelsson, MW Russell, K Zahka, HM Lever, AC Pereira, SD Colan, R Margossian, AM Murphy, C Canter, RG Bach, MT Wheeler, JW Rossano, AT Owens, H Bundgaard, L Benson, L Mestroni, MR Taylor, AR Patel, I Wilmot, P Thrush, JD Vargas, JH Soslow, JR Becker, CE Seidman, NK Lakdawala, AL Cirino, JE Krieger, L Sacilotto, E Arteaga, MO Antunes, EK Hall, L Choudhury, E Pahl, KY Lin, GD Lewis, AS Desai, KM Burns, JJ McMurray, CA MacRae, SD Solomon, EJ Orav, E Braunwald
Nature Medicine 2021
Single-Cell RNA Sequencing Uncovers Paracrine Functions of the Epicardial-Derived Cells in Arrhythmogenic Cardiomyopathy
P Yuan, SM Cheedipudi, L Rouhi, S Fan, L Simon, Z Zhao, K Hong, P Gurha, AJ Marian
Circulation 2021
Yes-Associated Protein (Yap) Is Up-Regulated in Heart Failure and Promotes Cardiac Fibroblast Proliferation
M Sharifi-Sanjani, M Berman, D Goncharov, M Alhamaydeh, TG Avolio, J Baust, B Chang, A Kobir, M Ross, CS Croix, SM Nouraie, CF McTiernan, CS Moravec, E Goncharova, IA Ghouleh
International journal of molecular sciences 2021
Molecular Genetic Basis of Hypertrophic Cardiomyopathy
AJ Marian
Circulation research 2021
Immune Cells and Immunotherapy for Cardiac Injury and Repair
JG Rurik, H Aghajanian, JA Epstein
Circulation research 2021
A Dual Role for Death Receptor 5 in Regulating Cardiac Fibroblast Function
MA Tanner, LA Grisanti
Frontiers in Cardiovascular Medicine 2021
Effect of sarcomere and mitochondria-related mutations on myocardial fibrosis in patients with hypertrophic cardiomyopathy
H Chung, Y Kim, CH Park, JY Kim, PK Min, YW Yoon, TH Kim, BK Lee, BK Hong, SJ Rim, HM Kwon, KA Lee, EY Choi
Journal of Cardiovascular Magnetic Resonance 2021
Targeting mitochondrial reactive oxygen species-mediated oxidative stress attenuates nicotine-induced cardiac remodeling and dysfunction
A Ramalingam, SB Budin, NM Fauzi, RH Ritchie, S Zainalabidin
Scientific Reports 2021
MicroRNA‑331 inhibits isoproterenol‑induced expression of profibrotic genes in cardiac myofibroblasts via the TGFβ/smad3 signaling pathway
F Yousefi, BM Soltani, S Rabbani
Scientific Reports 2021
Electrophysiological and Structural Remodeling of the Atria in a Mouse Model of Troponin-I Mutation Linked Hypertrophic Cardiomyopathy: Implications for Atrial Fibrillation
WW Lim, M Neo, S Thanigaimani, P Kuklik, AN Ganesan, DH Lau, T Tsoutsman, JM Kalman, C Semsarian, DA Saint, P Sanders
International journal of molecular sciences 2021
Effects of Angiotensin II Receptor Blockers on Ventricular Hypertrophy in Hypertrophic Cardiomyopathy: A Meta-Analysis of Randomized Controlled Trials
Y Liu, K Teramoto, VK Wing, T Supasiri, K Yin
Cardiovascular Drugs and Therapy 2021
Gene Expression Classifier Reveals Prognostic Osteosarcoma Microenvironment Molecular Subtypes
YJ Song, Y Xu, C Deng, X Zhu, J Fu, H Chen, J Lu, H Xu, G Song, Q Tang, J Wang
Frontiers in immunology 2021
ELTD1 Activation Induces an Endothelial-EMT Transition to a Myofibroblast Phenotype
H Sheldon, J Alexander, E Bridges, L Moreira, S Reilly, KH Ang, D Wang, S Lin, S Haider, AH Banham, AL Harris
International journal of molecular sciences 2021
An Insight on Multicentric Signaling of Angiotensin II in Cardiovascular system: A Recent Update
K Verma, M Pant, S Paliwal, J Dwivedi, S Sharma
Frontiers in pharmacology 2021
Interplay of Genotype and Substrate Stiffness in Driving the Hypertrophic Cardiomyopathy Phenotype in iPSC-Micro-Heart Muscle Arrays
J Guo, H Jiang, K Oguntuyo, B Rios, Z Boodram, N Huebsch
Cellular and Molecular Bioengineering 2021
Complex Relationship Between Cardiac Fibroblasts and Cardiomyocytes in Health and Disease
C Hall, K Gehmlich, C Denning, D Pavlovic
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease 2021
Biological Mechanisms and Therapeutic Opportunities in Mammographic Density and Breast Cancer Risk
M Archer, P Dasari, A Evdokiou, WV Ingman
Cancers 2021
The role of microRNAs in diseases and related signaling pathways
A Vaghf, B Khansarinejad, E Ghaznavi-Rad, M Mondanizadeh
Molecular Biology Reports 2021
Sacubitril/Valsartan Inhibits Cardiomyocyte Hypertrophy in Angiotensin II-Induced Hypertensive Mice Independent of a Blood Pressure-Lowering Effect
K Tashiro, T Kuwano, A Ideishi, H Morita, Y Idemoto, M Goto, Y Suematsu, S Miura
Cardiology Research 2020
The Dynamic Interplay Between Cardiac Inflammation and Fibrosis
TP Thomas, LA Grisanti
Frontiers in physiology 2020
Small Molecules Acting on Myofilaments as Treatments for Heart and Skeletal Muscle Diseases
K Alsulami, S Marston
International journal of molecular sciences 2020
Targeting cardiac fibrosis in heart failure with preserved ejection fraction: mirage or miracle?
M Sweeney, B Corden, SA Cook
EMBO Molecular Medicine 2020
Respiratory chain signalling is essential for adaptive remodelling following cardiac ischaemia
M Szibor, R Schreckenberg, Z Gizatullina, E Dufour, M Wiesnet, PK Dhandapani, G DebskaVielhaber, J Heidler, I Wittig, TA Nyman, U Gärtner, AR Hall, V Pell, C Viscomi, T Krieg, MP Murphy, T Braun, FN Gellerich, KD Schlüter, HT Jacobs
Journal of Cellular and Molecular Medicine 2020
Stochastic allelic expression as trigger for contractile imbalance in hypertrophic cardiomyopathy
J Montag, T Kraft
Biophysical Reviews 2020
Glutamyl-Prolyl-tRNA Synthetase Regulates Proline-Rich Pro-Fibrotic Protein Synthesis During Cardiac Fibrosis
J Wu, KC Subbaiah, LH Xie, F Jiang, ES Khor, D Mickelsen, JR Myers, WH Tang, P Yao
Circulation research 2020
Hypertrophic cardiomyopathy
M de Oliveira Antunes, TL Scudeler
IJC Heart & Vasculature 2020
Myosin Sequestration Regulates Sarcomere Function, Cardiomyocyte Energetics, and Metabolism, Informing the Pathogenesis of Hypertrophic Cardiomyopathy
CN Toepfer, AC Garfinkel, G Venturini, H Wakimoto, G Repetti, L Alamo, A Sharma, R Agarwal, JF Ewoldt, P Cloonan, J Letendre, M Lun, I Olivotto, S Colan, E Ashley, D Jacoby, M Michels, CS Redwood, HC Watkins, SM Day, JF Staples, R Padrón, A Chopra, CY Ho, CS Chen, AC Pereira, JG Seidman, CE Seidman
Circulation 2020
Burden of premature ventricular contractions beyond nonsustained ventricular tachycardia is related to the myocardial extracellular space expansion in patients with hypertrophic‐cardiomyopathy
H Chung, CH Park, Y Kim, JY Kim, PK Min, YW Yoon, KA Lee, BK Lee, BK Hong, TH Kim, SJ Rim, HM Kwon, EY Choi
Clinical Cardiology 2020
Anti-integrin αv therapy improves cardiac fibrosis after myocardial infarction by blunting cardiac PW1+ stromal cells
M Bouvet, O Claude, M Roux, D Skelly, N Masurkar, N Mougenot, S Nadaud, C Blanc, C Delacroix, S Chardonnet, C Pionneau, C Perret, E Yaniz-Galende, N Rosenthal, DA Trégouët, G Marazzi, JS Silvestre, D Sassoon, JS Hulot
Scientific Reports 2020
Unraveling the Genotype‐Phenotype Relationship in Hypertrophic Cardiomyopathy: Obesity‐Related Cardiac Defects as a Major Disease Modifier
EE Nollet, BD Westenbrink, RA de Boer, DW Kuster, J van der Velden
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease 2020
A Novel Bespoke Hypertrophic Scar Treatment: Actualizing Hybrid Pressure and Silicone Therapies with 3D Printing and Scanning
L Chow, K Yick, Y Sun, MS Leung, M Kwan, S Ng, A Yu, J Yip, Y Chan
International journal of bioprinting 2020
Impact of dietary fat and sucrose consumption on cardiac fibrosis in mice and rhesus monkeys
Niranjana Natarajan, Ana Vujic, Jishnu Das, Annie C Wang, Krystal K Phu, Spencer H Kiehm, Elisabeth M Ricci-Blair, Anthony Y Zhu, Kelli L. Vaughan, Julie A. Mattison, Ricki J. Colman, Richard Lee
JCI Insight 2019
Three in a Box: Understanding Cardiomyocyte, Fibroblast, and Innate Immune Cell Interactions to Orchestrate Cardiac Repair Processes
S Psarras, D Beis, S Nikouli, M Tsikitis, Y Capetanaki
Frontiers in Cardiovascular Medicine 2019
Cardiac Fibroblasts and the Extracellular Matrix in Regenerative and Nonregenerative Hearts
L Hortells, AK Johansen, KE Yutzey
Journal of Cardiovascular Development and Disease 2019
Stachydrine Ameliorates Cardiac Fibrosis Through Inhibition of Angiotensin II/Transformation Growth Factor β1 Fibrogenic Axis
X Liu, X Shan, H Chen, Z Li, P Zhao, C Zhang, W Guo, M Xu, R Lu
Frontiers in pharmacology 2019
An integrative systems approach identifies novel candidates in Marfan syndrome-related pathophysiology
R Bhushan, L Altinbas, M Jäger, M Zaradzki, D Lehmann, B Timmermann, NP Clayton, Y Zhu, K Kallenbach, G Kararigas, PN Robinson
Journal of Cellular and Molecular Medicine 2019
DNA Damage Response/TP53 Pathway Is Activated and Contributes to the Pathogenesis of Dilated Cardiomyopathy Associated with Lamin A/C Mutations
SN Chen, R Lombardi, J Karmouch, JY Tsai, GZ Czernuszewicz, M Taylor, L Mestroni, C Coarfa, P Gurha, AJ Marian
Circulation research 2019
Hypertrophic cardiomyopathy: genetics and clinical perspectives
CM Wolf
Cardiovascular diagnosis and therapy 2019
Widespread Translational Control of Fibrosis in the Human Heart by RNA-Binding Proteins
S Chothani, S Schäfer, E Adami, S Viswanathan, AA Widjaja, SR Langley, J Tan, M Wang, NM Quaife, CJ Pua, G D'Agostino, SG Shekeran, BL George, S Lim, EY Cao, S van Heesch, F Witte, LE Felkin, EG Christodoulou, J Dong, S Blachut, G Patone, PJ Barton, N Hubner, SA Cook, OJ Rackham
Circulation 2019
The Extracellular Matrix in Ischemic and Nonischemic Heart Failure
NG Frangogiannis
Circulation research 2019
Altered force generation and cell-to-cell contractile imbalance in hypertrophic cardiomyopathy
T Kraft, J Montag
Pflügers Archiv - European Journal of Physiology 2019
Metabolic Changes in Spontaneously Hypertensive Rat Hearts Precede Cardiac Dysfunction and Left Ventricular Hypertrophy
J Li, BA Kemp, NL Howell, J Massey, K Mińczuk, Q Huang, MD Chordia, RJ Roy, JT Patrie, GE Davogustto, CM Kramer, FH Epstein, RM Carey, H Taegtmeyer, SR Keller, BK Kundu
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease 2019
Does the Flow Know? Mitral Regurgitant Jet Direction and Need for Valve Repair in Hypertrophic Obstructive Cardiomyopathy
E Schwammenthal, AA Hagège, RA Levine
Journal of the American Society of Echocardiography 2019
miR‑216a exacerbates TGF‑β‑induced myofibroblast transdifferentiation via PTEN/AKT signaling
C Qu, X Liu, T Ye, L Wang, S Liu, X Zhou, G Wu, J Lin, S Shi, B Yang
Molecular medicine reports 2019
Co‑culturing with hypoxia pre‑conditioned mesenchymal stem cells as a new strategy for the prevention of irradiation‑induced fibroblast‑to‑myofibroblast transition
L Zhuang, W Xia, M Hou
Oncology reports 2019
Long-term outcomes of childhood onset Noonan compared to sarcomere hypertrophic cardiomyopathy
E Kaltenecker, J Schleihauf, C Meierhofer, N Shehu, N Mkrtchyan, A Hager, A Kühn, J Cleuziou, K Klingel, H Seidel, M Zenker, P Ewert, G Hessling, CM Wolf
Cardiovascular diagnosis and therapy 2019
The relationship between myocardial fibrosis detected by cardiac magnetic resonance and Tp‐e interval, 5‐year sudden cardiac death risk score in hypertrophic cardiomyopathy patients
AR Demir, Ö Celik, S Sevinç, B Uygur, S Kahraman, E Yilmaz, M Cemek, Y Onal, M Erturk
Annals of noninvasive electrocardiology : the official journal of the International Society for Holter and Noninvasive Electrocardiology, Inc 2019
Baseline Characteristics of the VANISH Cohort
AA Raja, L Shi, SM Day, M Russell, K Zahka, H Lever, SD Colan, R Margossian, EK Hall, J Becker, JL Jefferies, AR Patel, L Choudhury, AM Murphy, C Canter, R Bach, M Taylor, L Mestroni, MT Wheeler, L Benson, AT Owens, J Rossano, KY Lin, E Pahl, AC Pereira, H Bundgaard, GD Lewis, JD Vargas, AL Cirino, JJ McMurray, CA MacRae, SD Solomon, EJ Orav, E Braunwald, CY Ho
Circulation. Heart failure 2019
Myocardial fibrosis, inflammation, and altered cardiac gene expression profiles in rats exposed to a predator-based model of posttraumatic stress disorder
BR Rorabaugh, NW Mabe, SL Seeley, TS Stoops, KE Mucher, CP Ney, CS Goodman, BJ Hertenstein, AE Rush, CD Kasler, AM Sargeant, PR Zoladz
Stress (Amsterdam, Netherlands) 2019
Allele-specific differences in transcriptome, miRNome, and mitochondrial function in two hypertrophic cardiomyopathy mouse models
Styliani Vakrou, Ryuya Fukunaga, D. Brian Foster, Lars Sorensen, Yamin Liu, Yufan Guan, Kirubel Woldemichael, Roberto Pineda-Reyes, Ting Liu, Jil Tardiff, Leslie Leinwand, Carlo G. Tocchetti, Theodore Abraham, Brian O'Rourke, Miguel A. Aon, M. Roselle Abraham
JCI Insight 2018
Testosterone plays a permissive role in angiotensin II-induced hypertension and cardiac hypertrophy in male rats†
JS Mishra, AS More, K Gopalakrishnan, S Kumar
Biology of reproduction 2018
miR-133: A Suppressor of Cardiac Remodeling?
N Li, H Zhou, Q Tang
Frontiers in pharmacology 2018
PIMT/NCOA6IP Deletion in the Mouse Heart Causes Delayed Cardiomyopathy Attributable to Perturbation in Energy Metabolism
Y Jia, N Liu, N Viswakarma, R Sun, M Schipma, M Shang, E Thorp, Y Kanwar, B Thimmapaya, J Reddy
International journal of molecular sciences 2018
Myofibroblast-Specific TGFβ Receptor II Signaling in the Fibrotic Response to Cardiac Myosin Binding Protein C-Induced Cardiomyopathy
Q Meng, B Bhandary, S Bhuiyan, J James, H Osinska, I Valiente-Alandi, K Shay-Winkler, J Gulick, JD Molkentin, BC Blaxall, J Robbins
Circulation research 2018
Gr-1+ Cells Other Than Ly6G+ Neutrophils Limit Virus Replication and Promote Myocardial Inflammation and Fibrosis Following Coxsackievirus B3 Infection of Mice
D Xu, P Wang, J Yang, Q Qian, M Li, L Wei, W Xu
Frontiers in Cellular and Infection Microbiology 2018
Transient fibrosis resolves via fibroblast inactivation in the regenerating zebrafish heart
H Sánchez-Iranzo, M Galardi-Castilla, A Sanz-Morejón, JM González-Rosa, R Costa, A Ernst, JS de Aja, X Langa, N Mercader
Proceedings of the National Academy of Sciences 2018
Successful knock-in of Hypertrophic Cardiomyopathy-mutation R723G into the MYH7 gene mimics HCM pathology in pigs
J Montag, B Petersen, AK Flögel, E Becker, A Lucas-Hahn, GJ Cost, C Mühlfeld, T Kraft, H Niemann, B Brenner
Scientific Reports 2018
Metabolic changes in hypertrophic cardiomyopathies: scientific update from the Working Group of Myocardial Function of the European Society of Cardiology
J van der Velden, CG Tocchetti, G Varricchi, A Bianco, V Sequeira, D Hilfiker-Kleiner, N Hamdani, AF Leite-Moreira, M Mayr, I Falcão-Pires, T Thum, DK Dawson, JL Balligand, S Heymans
Cardiovascular Research 2018
Region of Interest analysis using mass spectrometry imaging of mitochondrial and sarcomeric proteins in acute cardiac infarction tissue
Y Yajima, T Hiratsuka, Y Kakimoto, S Ogawa, K Shima, Y Yamazaki, K Yoshikawa, K Tamaki, T Tsuruyama
Scientific Reports 2018
Burst-Like Transcription of Mutant and Wildtype MYH7-Alleles as Possible Origin of Cell-to-Cell Contractile Imbalance in Hypertrophic Cardiomyopathy
J Montag, K Kowalski, M Makul, P Ernstberger, A Radocaj, J Beck, E Becker, S Tripathi, B Keyser, C Mühlfeld, K Wissel, A Pich, J van der Velden, CG dos Remedios, A Perrot, A Francino, F Navarro-López, B Brenner, T Kraft
Frontiers in physiology 2018
Hypertrophy Regression With N-Acetylcysteine in Hypertrophic Cardiomyopathy (HALT-HCM)Novelty and Significance: A Randomized, Placebo-Controlled, Double-Blind Pilot Study
AJ Marian, Y Tan, L Li, J Chang, P Syrris, M Hessabi, MH Rahbar, JT Willerson, BY Cheong, CY Liu, NS Kleiman, DA Bluemke, SF Nagueh
Circulation research 2018
Biomarkers of Myocardial Fibrosis: Revealing the Natural History of Fibrogenesis in Fabry Disease Cardiomyopathy
P Aguiar, O Azevedo, R Pinto, J Marino, C Cardoso, N Sousa, D Cunha, D Hughes, JL Soares
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease 2018
Genotype and Lifetime Burden of Disease in Hypertrophic Cardiomyopathy: Insights From the Sarcomeric Human Cardiomyopathy Registry (SHaRe)
CY Ho, SM Day, EA Ashley, M Michels, AC Pereira, D Jacoby, AL Cirino, JC Fox, NK Lakdawala, JS Ware, CA Caleshu, AS Helms, SD Colan, F Girolami, F Cecchi, CE Seidman, G Sajeev, J Signorovitch, EM Green, I Olivotto
Circulation 2018
Cardiac Fibrosis in Proteotoxic Cardiac Disease is Dependent Upon Myofibroblast TGF‐β Signaling
B Bhandary, Q Meng, J James, H Osinska, J Gulick, I ValienteAlandi, MA Sargent, S Bhuiyan, BC Blaxall, JD Molkentin, J Robbins
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease 2018
Progression of myocardial fibrosis in hypertrophic cardiomyopathy: mechanisms and clinical implications
B Raman, R Ariga, M Spartera, S Sivalokanathan, K Chan, S Dass, SE Petersen, MJ Daniels, J Francis, R Smillie, AJ Lewandowski, EO Ohuma, C Rodgers, CM Kramer, M Mahmod, H Watkins, S Neubauer
European Heart Journal - Cardiovascular Imaging 2018
Histone lysine dimethyl-demethylase KDM3A controls pathological cardiac hypertrophy and fibrosis
QJ Zhang, TA Tran, M Wang, MJ Ranek, KM Kokkonen-Simon, J Gao, X Luo, W Tan, V Kyrychenko, L Liao, J Xu, JA Hill, EN Olson, DA Kass, ED Martinez, ZP Liu
Nature Communications 2018
Fibroblast-specific genetic dissection of TGFbeta-Smad2/3 signaling in cardiac fibrosis
Hadi Khalil, Onur kanisicak, Vikram Prasad, Robert, Nathan Correll, Xing Fu, Tobias Schips, Ronald Vagnozzi, Ruijie Liu, Thanh Huynh, Se-Jin Lee, Jason Karch, Jeffrey D. Molkentin
Journal of Clinical Investigation 2017
Nonmyocyte ERK1/2 Signaling Contributes to Load-Induced Cardiomyopathy in Marfan Mice
Rosanne Rouf, Elena Gallo MacFarlane, Eiki Takimoto, Rahul Chaudhary, Varun Nagpal, Peter Rainer, Julia G. Bindman, Elizabeth E. Gerber, Djahida Bedja, Christopher Schiefer, Karen Miller, Guangshuo Zhu, Loretha Myers, Nuria Amat-Alarcon, Dong I. Lee, Norimichi Koitabashi, Daniel P. Judge, David A. Kass, Harry C. Dietz, III
JCI Insight 2017
New Role for Interleukin‐13 Receptor α1 in Myocardial Homeostasis and Heart Failure
U Amit, D Kain, A Wagner, A Sahu, Y NevoCaspi, N Gonen, N Molotski, T Konfino, N Landa, N NaftaliShani, G Blum, E Merquiol, D KaroAtar, Y Kanfi, G Paret, A Munitz, HY Cohen, E Ruppin, S Hannenhalli, J Leor
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease 2017
Cardiovascular homeostasis dependence on MICU2, a regulatory subunit of the mitochondrial calcium uniporter
AG Bick, H Wakimoto, KJ Kamer, Y Sancak, O Goldberger, A Axelsson, DM DeLaughter, JM Gorham, VK Mootha, JG Seidman, CE Seidman
Proceedings of the National Academy of Sciences 2017
Th1 effector T cells selectively orchestrate cardiac fibrosis in nonischemic heart failure
T Nevers, AM Salvador, F Velazquez, N Ngwenyama, FJ Carrillo-Salinas, M Aronovitz, RM Blanton, P Alcaide
Journal of Experimental Medicine 2017
Molecular Characterization of Pediatric Restrictive Cardiomyopathy from Integrative Genomics
TN Rindler, RB Hinton, N Salomonis, SM Ware
Scientific Reports 2017
Differential regulation of miRNA and mRNA expression in the myocardium of Nrf2 knockout mice
JM Quiles, M Narasimhan, G Shanmugam, B Milash, JR Hoidal, NS Rajasekaran
BMC Genomics 2017
Emerging pharmacologic and structural therapies for hypertrophic cardiomyopathy
DJ Philipson, EC DePasquale, EH Yang, AS Baas
Heart Failure Reviews 2017
Hypertrophic Cardiomyopathy: Genetics, Pathogenesis, Clinical Manifestations, Diagnosis, and Therapy
AJ Marian, E Braunwald
Circulation research 2017
Pediatric Cardiomyopathies
TM Lee, DT Hsu, P Kantor, JA Towbin, SM Ware, SD Colan, WK Chung, JL Jefferies, JW Rossano, CD Castleberry, LJ Addonizio, AK Lal, JM Lamour, EM Miller, PT Thrush, JD Czachor, H Razoky, A Hill, SE Lipshultz
Circulation research 2017
TGF-β-Induced Endothelial-Mesenchymal Transition in Fibrotic Diseases
E Pardali, G Sanchez-Duffhues, M Gomez-Puerto, P Dijke
International journal of molecular sciences 2017
Pathophysiology of Aortic Valve Stenosis: Is It Both Fibrocalcific and Sex Specific?
Y Sritharen, M Enriquez-Sarano, HV Schaff, G Casaclang-Verzosa, JD Miller
Physiology (Bethesda, Md.) 2017
Luteolin-7-diglucuronide attenuates isoproterenol-induced myocardial injury and fibrosis in mice
B Ning, Y Zhang, D Wu, J Cui, L Liu, P Wang, W Wang, W Zhu, Y Chen, T Zhang
Acta Pharmacologica Sinica 2017
Myocardial fibrosis: biomedical research from bench to bedside: Myocardial fibrosis: biomedical research from bench to bedside
M Gyöngyösi, J Winkler, I Ramos, QT Do, H Firat, K McDonald, A González, T Thum, J Díez, F Jaisser, A Pizard, F Zannad
European Journal of Heart Failure 2017
Biophysical properties of human β-cardiac myosin with converter mutations that cause hypertrophic cardiomyopathy
M Kawana, SS Sarkar, S Sutton, KM Ruppel, JA Spudich
Science Advances 2017
Valsartan for Attenuating Disease Evolution in Early Sarcomeric Hypertrophic Cardiomyopathy: The Design of the VANISH Trial
CY Ho, JJ McMurray, AL Cirino, SD Colan, SM Day, AS Desai, SE Lipshultz, CA MacRae, L Shi, SD Solomon, EJ Orav, E Braunwald
American Heart Journal 2017
Cardiac Function Remains Impaired Despite Reversible Cardiac Remodeling after Acute Experimental Viral Myocarditis
PM Becher, F Gotzhein, K Klingel, F Escher, S Blankenberg, D Westermann, D Lindner
Journal of Immunology Research 2017
Cardiac Fibroblast Activation Post-Myocardial Infarction: Current Knowledge Gaps
Y Ma, RP Iyer, M Jung, MP Czubryt, ML Lindsey
Trends in Pharmacological Sciences 2017
Sexual dimorphism in the fetal cardiac response to maternal nutrient restriction
S Muralimanoharan, C Li, ES Nakayasu, CP Casey, TO Metz, PW Nathanielsz, A Maloyan
Journal of Molecular and Cellular Cardiology 2017
Lipoprotein(a) in patients with aortic stenosis: Insights from cardiovascular magnetic resonance
VS Vassiliou, PD Flynn, CE Raphael, S Newsome, T Khan, A Ali, B Halliday, AS Bruengger, T Malley, P Sharma, S Selvendran, N Aggarwal, A Sri, H Berry, J Donovan, W Lam, D Auger, SA Cook, DJ Pennell, SK Prasad, X Cheng
PloS one 2017
Olmesartan attenuates pressure-overload- or post-infarction-induced cardiac remodeling in mice
Q Wang, Z Chen, X Huang, L Chen, B Chen, Y Zhu, S Cao, W Liao, J Bin, M Kitakaze, Y Liao
Oncotarget 2017
Molecular Profiling of Dilated Cardiomyopathy that Progresses to Heart Failure
Michael Burke, Stephen Chang, Hiroko Wakimoto, Joshua Gorham, David Conner, Danos Christodoulou, Michael Parfenov, Steven DePalma, Seda Eminaga, Tetsuo Konno, Jonathan Seidman, Christine Seidman
JCI Insight 2016
Autonomous and Non-autonomous Defects Underlie Hypertrophic Cardiomyopathy in BRAF-Mutant hiPSC-Derived Cardiomyocytes
R Josowitz, S Mulero-Navarro, NA Rodriguez, C Falce, N Cohen, EM Ullian, LA Weiss, KA Rauen, EA Sobie, BD Gelb
Stem Cell Reports 2016
Integrating genetics and medicine: Disease-modifying treatment strategies for hypertrophic cardiomyopathy
CY Ho
Progress in Pediatric Cardiology 2016
Cardiac Fibrosis: The Fibroblast Awakens
JG Travers, FA Kamal, J Robbins, KE Yutzey, BC Blaxall
Circulation research 2016
Integrative Analysis of PRKAG2 Cardiomyopathy iPS and Microtissue Models Identifies AMPK as a Regulator of Metabolism, Survival, and Fibrosis
JT Hinson, A Chopra, A Lowe, CC Sheng, RM Gupta, R Kuppusamy, J O'Sullivan, G Rowe, H Wakimoto, J Gorham, K Zhang, K Musunuru, RE Gerszten, SM Wu, CS Chen, JG Seidman, CE Seidman
Cell Reports 2016
Relevance of mouse models of cardiac fibrosis and hypertrophy in cardiac research
V Rai, P Sharma, S Agrawal, DK Agrawal
Molecular and Cellular Biochemistry 2016
Cardiac Troponin and Tropomyosin: Structural and Cellular Perspectives to Unveil the Hypertrophic Cardiomyopathy Phenotype
MA Marques, GA de Oliveira
Frontiers in physiology 2016
Clinical and Mechanistic Insights Into the Genetics of Cardiomyopathy
MA Burke, SA Cook, JG Seidman, CE Seidman
Journal of the American College of Cardiology 2016
Transcriptional control of cardiac fibroblast plasticity
JK Lighthouse, EM Small
Journal of Molecular and Cellular Cardiology 2016
Downregulation of GSTK1 Is a Common Mechanism Underlying Hypertrophic Cardiomyopathy
S Sasagawa, Y Nishimura, S Okabe, S Murakami, Y Ashikawa, M Yuge, K Kawaguchi, R Kawase, R Okamoto, M Ito, T Tanaka
Frontiers in pharmacology 2016
Cardiovascular magnetic resonance detects the progression of impaired myocardial perfusion reserve and increased left-ventricular mass in mice fed a high-fat diet
NK Naresh, JT Butcher, RJ Lye, X Chen, BE Isakson, LM Gan, CM Kramer, BH Annex, FH Epstein
Journal of Cardiovascular Magnetic Resonance 2016
Cardiomyocyte-Specific Ablation of Med1 Subunit of the Mediator Complex Causes Lethal Dilated Cardiomyopathy in Mice
Y Jia, HC Chang, MJ Schipma, J Liu, V Shete, N Liu, T Sato, EB Thorp, PM Barger, YJ Zhu, N Viswakarma, YS Kanwar, H Ardehali, B Thimmapaya, JK Reddy, AS Lewin
PloS one 2016
Sexual dimorphism in activation of placental autophagy in obese women with evidence for fetal programming from a placenta-specific mouse model
S Muralimanoharan, X Gao, S Weintraub, L Myatt, A Maloyan
Autophagy 2016
Epicardium-derived fibroblasts in heart development and disease
M Fang, FL Xiang, CM Braitsch, KE Yutzey
Journal of Molecular and Cellular Cardiology 2016
Current Protocols in Molecular Biology: Cell Proliferation Markers in Paraffin-Embedded Sections
S Eminaga, P Teekakirikul, CE Seidman, JG Seidman
Current Protocols in Molecular Biology: Cell Proliferation Markers in Paraffin-Embedded Sections 2016
Periostin as a multifunctional modulator of the wound healing response
JT Walker, K McLeod, S Kim, SJ Conway, DW Hamilton
Cell and Tissue Research 2016
Kcne2 deletion attenuates acute post-ischaemia/reperfusion myocardial infarction
Z Hu, SM Crump, P Zhang, GW Abbott
Cardiovascular Research 2016
A small-molecule inhibitor of sarcomere contractility suppresses hypertrophic cardiomyopathy in mice
EM Green, H Wakimoto, RL Anderson, MJ Evanchik, JM Gorham, BC Harrison, M Henze, R Kawas, JD Oslob, HM Rodriguez, Y Song, W Wan, LA Leinwand, JA Spudich, RS McDowell, JG Seidman, CE Seidman
Science 2016
sFRP2 activates Wnt/β-catenin signaling in cardiac fibroblasts: differential roles in cell growth, energy metabolism, and extracellular matrix remodeling
H Lin, M Angeli, KJ Chung, C Ejimadu, AR Rosa, T Lee
American journal of physiology. Cell physiology 2016
Drug Therapy for Hypertrophic Cardiomypathy: Physiology and Practice
V. Sherrid M
Current cardiology reviews 2016
Increased Transforming Growth Factor-β Levels Associated With Cardiac Adverse Events in Hypertrophic Cardiomyopathy: High TGF-β worsens prognosis in HCM
B Ayça, I Sahin, SH Kucuk, F Akin, D Kafadar, M Avşar, II Avci, B Gungor, E Okuyan, MH Dinckal
Clinical Cardiology 2015
Integrated Glycoprotein Immobilization Method for Glycopeptide and Glycan Analysis of Cardiac Hypertrophy
S Yang, S Mishra, L Chen, J Zhou, DW Chan, S Chatterjee, H Zhang
Analytical Chemistry 2015
MiR-125b is Critical for Fibroblast-to-Myofibroblast Transition and Cardiac Fibrosis
V Nagpal, R Rai, AT Place, SB Murphy, SK Verma, AK Ghosh, DE Vaughan
Circulation 2015
Research priorities in sarcomeric cardiomyopathies
J der Velden, CY Ho, JC Tardiff, I Olivotto, BC Knollmann, L Carrier
Cardiovascular Research 2015
Targeted Mybpc3 Knock-Out Mice with Cardiac Hypertrophy Exhibit Structural Mitral Valve Abnormalities
D Judge, H Neamatalla, R Norris, R Levine, J Butcher, N Vignier, K Kang, Q Nguyen, P Bruneval, MC Perier, E Messas, X Jeunemaitre, A Vlaming, R Markwald, L Carrier, A Hagège
Journal of Cardiovascular Development and Disease 2015
Mitral valve disease—morphology and mechanisms
RA Levine, AA Hagége, DP Judge, M Padala, JP Dal-Bianco, E Aikawa, J Beaudoin, J Bischoff, N Bouatia-Naji, P Bruneval, JT Butcher, A Carpentier, M Chaput, AH Chester, C Clusel, FN Delling, HC Dietz, C Dina, R Durst, L Fernandez-Friera, MD Handschumacher, MO Jensen, XP Jeunemaitre, HL Marec, TL Tourneau, RR Markwald, J Mérot, E Messas, DP Milan, T Neri, RA Norris, D Peal, M Perrocheau, V Probst, M Pucéat, N Rosenthal, J Solis, JJ Schott, E Schwammenthal, SA Slaugenhaupt, JK Song, MH Yacoub
Nature Reviews Cardiology 2015
A Food-Derived Flavonoid Luteolin Protects against Angiotensin II-Induced Cardiac Remodeling
A Nakayama, H Morita, T Nakao, T Yamaguchi, T Sumida, Y Ikeda, H Kumagai, Y Motozawa, T Takahashi, A Imaizumi, T Hashimoto, R Nagai, I Komuro, LE Quintas
PloS one 2015
Immune Cell and Other Noncardiomyocyte Regulation of Cardiac Hypertrophy and Remodeling
RA Frieler, RM Mortensen
Circulation 2015
Heart Failure and Atrial Fibrillation: From Basic Science to Clinical Practice
J Ferreira, M Santos
International journal of molecular sciences 2015
Cardiac fibroblasts: from development to heart failure
T Moore-Morris, N Guimarães-Camboa, KE Yutzey, M Pucéat, SM Evans
Journal of Molecular Medicine 2015
INHERIT (INHibition of the renin angiotensin system in hypertrophic cardiomyopathy and the Effect on hypertrophy—a Randomised Intervention Trial with losartan)
I Olivotto, EA Ashley
Global Cardiology Science and Practice 2015
Towards causally cohesive genotype-phenotype modelling for characterization of the soft-tissue mechanics of the heart in normal and pathological geometries
O Nordbo, AB Gjuvsland, A Nermoen, S Land, S Niederer, P Lamata, J Lee, NP Smith, SW Omholt, JO Vik
Journal of The Royal Society Interface 2015
For whom the cells pull: Hydrogel and micropost devices for measuring traction forces
AJ Ribeiro, AK Denisin, RE Wilson, BL Pruitt
Methods 2015
5’RNA-seq identifies Fhl1 as a Modifier in Hypertrophic Cardiomyopathy
Danos Christodoulou, Hiroko Wakimoto, Kenji Onoue, Seda Eminaga, Joshua Gorham, Steven DePalma, Daniel Herman, Polakit Teekakirikul, David Conner, David McKean, Andrea Domenighetti, Anton Aboukhalil, Stephen Chang, Gyan Srivastava, Barbara McDonough, Philip De Jager, Ju Chen, Martha Bulyk, Jochen Muehlschlegel, Christine Seidman, Jonathan Seidman
Journal of Clinical Investigation 2014
Resident fibroblast lineages mediate pressure overload-induced cardiac fibrosis
Thomas Moore-Morris, Nuno Guimarães-Camboa, Indroneal Banerjee, Alexander Zambon, Tatiana Kisseleva, Aurelie Velayoudon, William B. Stallcup, Yusu Gu, Nancy Dalton, Martha Cedenilla, Rafael Gomez-Amaro, Bin Zhou, David A. Brenner, Kirk Peterson, Ju Chen, Sylvia Evans
Journal of Clinical Investigation 2014
Klotho and Phosphate Are Modulators of Pathologic Uremic Cardiac Remodeling
MC Hu, M Shi, HJ Cho, B Adams-Huet, J Paek, K Hill, J Shelton, AP Amaral, C Faul, M Taniguchi, M Wolf, M Brand, M Takahashi, M Kuro-o, JA Hill, OW Moe
Journal of the American Society of Nephrology : JASN 2014
 -Myosin Heavy Chain Variant Val606Met Causes Very Mild Hypertrophic Cardiomyopathy in Mice, but Exacerbates HCM Phenotypes in Mice Carrying Other HCM Mutations
R Blankenburg, K Hackert, S Wurster, R Deenen, JG Seidman, CE Seidman, MJ Lohse, JP Schmitt
Circulation research 2014
(-)-Epicatechin improves mitochondrial-related protein levels and ameliorates oxidative stress in dystrophic δ-sarcoglycan null mouse striated muscle
I Ramirez-Sanchez, SD los Santos, S Gonzalez-Basurto, P Canto, P Mendoza-Lorenzo, C Palma-Flores, G Ceballos-Reyes, F Villarreal, A Zentella-Dehesa, R Coral-Vazquez
FEBS Journal 2014
Cardiac steatosis potentiates angiotensin II effects in the heart
DJ Glenn, MC Cardema, W Ni, Y Zhang, Y Yeghiazarians, D Grapov, O Fiehn, DG Gardner
American journal of physiology. Heart and circulatory physiology 2014
A role for membrane shape and information processing in cardiac physiology
R Knöll
Pflügers Archiv - European Journal of Physiology 2014
Hypertrophic cardiomyopathy in 2013: Current speculations and future perspectives
GK Efthimiadis, ED Pagourelias, T Gossios, T Zegkos
World journal of cardiology 2014
Hypertrophic cardiomyopathy: a heart in need of an energy bar?
S Vakrou, MR Abraham
Frontiers in physiology 2014
Granule cargo release from bone marrow-derived cells sustains cardiac hypertrophy
F Yang, A Dong, J Ahamed, M Sunkara, SS Smyth
American journal of physiology. Heart and circulatory physiology 2014
The Genetic Basis of Aortic Aneurysm
ME Lindsay, HC Dietz
Cold Spring Harbor Perspectives in Medicine 2014
Aldosterone Promotes Cardiac Endothelial Cell Proliferation In Vivo
B Gravez, A Tarjus, V Pelloux, A Ouvrard-Pascaud, C Delcayre, J Samuel, K Clement, N Farman, F Jaisser, S Messaoudi
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease 2014
Mammalian target of rapamycin is essential for cardiomyocyte survival and heart development in mice
P Zhang, T Shan, X Liang, C Deng, S Kuang
Biochemical and Biophysical Research Communications 2014
Myocardial fibrosis in patients with myotonic dystrophy type 1: a cardiovascular magnetic resonance study
H Petri, K Ahtarovski, N Vejlstrup, J Vissing, N Witting, L Køber, H Bundgaard
Journal of Cardiovascular Magnetic Resonance 2014
Familial hypertrophic cardiomyopathy: functional variance among individual cardiomyocytes as a trigger of FHC-phenotype development
B Brenner, B Seebohm, S Tripathi, J Montag, T Kraft
Frontiers in physiology 2014
Cardiovascular remodelling in coronary artery disease and heart failure
G Heusch, P Libby, B Gersh, D Yellon, M Böhm, G Lopaschuk, L Opie
The Lancet 2014
Adverse fibrosis in the aging heart depends on signaling between myeloid and mesenchymal cells; role of inflammatory fibroblasts
KA Cieslik, JA Trial, JR Crawford, GE Taffet, ML Entman
Journal of Molecular and Cellular Cardiology 2014
Identifying Gastric Cancer Related Genes Using the Shortest Path Algorithm and Protein-Protein Interaction Network
Y Jiang, Y Shu, Y Shi, LP Li, F Yuan, H Ren
BioMed Research International 2014
Fibrosis-Related Biomarkers and Risk of Total and Cause-Specific Mortality: The Cardiovascular Health Study
I Agarwal, NL Glazer, E Barasch, ML Biggs, L Djousse, AL Fitzpatrick, JS Gottdiener, JH Ix, JR Kizer, EB Rimm, DS Siscovick, RP Tracy, SJ Zieman, KJ Mukamal
American Journal of Epidemiology 2014
High Glucose Induces Sumoylation of Smad4 via SUMO2/3 in Mesangial Cells
X Zhou, C Gao, W Huang, M Yang, G Chen, L Jiang, F Gou, H Feng, N Ai, Y Xu
BioMed Research International 2014
High sensitivity of late gadolinium enhancement for predicting microscopic myocardial scarring in biopsied specimens in hypertrophic cardiomyopathy
T Konno, K Hayashi, N Fujino, Y Nagata, A Hodatsu, E Masuta, K Sakata, H Nakamura, M Kawashiri, M Yamagishi
PloS one 2014
Searching novel diagnostic markers and targets for therapy of CKD
P Kavvadas, JC Dussaule, C Chatziantoniou
Kidney International Supplements 2014
Decade in review—cardiomyopathies: Cardiomyopathy on the move
MH Yacoub
Nature Reviews Cardiology 2014
Inhibition of Periostin Expression Protects against the Development of Renal Inflammation and Fibrosis
M Mael-Ainin, A Abed, SJ Conway, JC Dussaule, C Chatziantoniou
Journal of the American Society of Nephrology : JASN 2014
Right Ventricular Epicardial Fibrosis in Mice With Sternal Segment Dislocation
HA Adissu, GA Medhanie, L Morikawa, JK White, S Newbigging, C McKerlie
Veterinary pathology 2014
A Role for Partial Endothelial-Mesenchymal Transitions in Angiogenesis?
KM Welch-Reardon, N Wu, CC Hughes
Arteriosclerosis, thrombosis, and vascular biology 2014
Hypertrophic cardiomyopathy: how do mutations lead to disease?
Marsiglia JD, Pereira AC
Arquivos brasileiros de cardiologia 2014
Stimulating myocardial regeneration with periostin Peptide in large mammals improves function post-myocardial infarction but increases myocardial fibrosis
D Ladage, E Yaniz-Galende, K Rapti, K Ishikawa, L Tilemann, S Shapiro, Y Takewa, J Muller-Ehmsen, M Schwarz, MJ Garcia, J Sanz, RJ Hajjar, Y Kawase
PloS one 2013
Allele-Specific Silencing of Mutant Myh6 Transcripts in Mice Suppresses Hypertrophic Cardiomyopathy
J Jiang, H Wakimoto, JG Seidman, CE Seidman
Science 2013
A clinical approach to inherited hypertrophy: the use of family history in diagnosis, risk assessment, and management
KE Dunn, C Caleshu, AL Cirino, CY Ho, EA Ashley
Circulation. Cardiovascular genetics 2013
Fibroblast growth factor receptor 1 signaling in adult cardiomyocytes increases contractility and results in a hypertrophic cardiomyopathy
SN Cilvik, JI Wang, KJ Lavine, K Uchida, A Castro, CM Gierasch, CJ Weinheimer, SL House, A Kovacs, CG Nichols, DM Ornitz
PloS one 2013
Stimulation of α1a adrenergic receptors induces cellular proliferation or antiproliferative hypertrophy dependent solely on agonist concentration
B Lei, DA Schwinn, DP Morris
PloS one 2013
Mineralocorticoid receptor antagonism attenuates experimental pulmonary hypertension
IR Preston, KD Sagliani, RR Warburton, NS Hill, BL Fanburg, IZ Jaffe
American journal of physiology. Lung cellular and molecular physiology 2013
Current perspectives in genetic cardiovascular disorders: from basic to clinical aspects
M Kawashiri, K Hayashi, T Konno, N Fujino, H Ino, M Yamagishi
Heart and Vessels 2013
Identification and comparative analyses of myocardial miRNAs involved in the fetal response to maternal obesity
A Maloyan, S Muralimanoharan, S Huffman, LA Cox, PW Nathanielsz, L Myatt, MJ Nijland
2013
p90 ribosomal S6 kinase 3 contributes to cardiac insufficiency in  -tropomyosin Glu180Gly transgenic mice
CL Passariello, M Gayanilo, MD Kritzer, H Thakur, Z Cozacov, F Rusconi, D Wieczorek, M Sanders, J Li, MS Kapiloff
American journal of physiology. Heart and circulatory physiology 2013
The role of periostin in tissue remodeling across health and disease
SJ Conway, K Izuhara, Y Kudo, J Litvin, R Markwald, G Ouyang, JR Arron, CT Holweg, A Kudo
Cellular and Molecular Life Sciences 2013
A Novel Immunomodulator, FTY-720 Reverses Existing Cardiac Hypertrophy and Fibrosis From Pressure Overload by Targeting NFAT (Nuclear Factor of Activated T-cells) Signaling and Periostin
W Liu, M Zi, H Tsui, SK Chowdhury, L Zeef, QJ Meng, M Travis, S Prehar, A Berry, NA Hanley, L Neyses, RP Xiao, D Oceandy, Y Ke, RJ Solaro, EJ Cartwright, M Lei, X Wang
Circulation. Heart failure 2013
Severity of cardiomyopathy associated with adenine nucleotide translocator-1 deficiency correlates with mtDNA haplogroup
KA Strauss, L DuBiner, M Simon, M Zaragoza, PP Sengupta, P Li, N Narula, S Dreike, J Platt, V Procaccio, XR Ortiz-Gonzalez, EG Puffenberger, RI Kelley, DH Morton, J Narula, DC Wallace
Proceedings of the National Academy of Sciences 2013
Establishment of a novel murine model of ischemic cardiomyopathy with multiple diffuse coronary lesions
H Nakaoka, Y Nakagawa-Toyama, M Nishida, T Okada, R Kawase, T Yamashita, M Yuasa-Kawase, K Nakatani, D Masuda, T Ohama, T Sonobe, M Shirai, I Komuro, S Yamashita
PloS one 2013
Effects of Losartan on Left Ventricular Hypertrophy and Fibrosis in Patients With Nonobstructive Hypertrophic Cardiomyopathy
YJ Shimada, JJ Passeri, AL Baggish, C O'Callaghan, PA Lowry, G Yannekis, S Abbara, BB Ghoshhajra, RD Rothman, CY Ho, JL Januzzi, CE Seidman, MA Fifer
JACC: Heart Failure 2013
Smooth muscle LDL receptor-related protein-1 deletion induces aortic insufficiency and promotes vascular cardiomyopathy in mice
JE Basford, S Koch, A Anjak, VP Singh, EG Krause, N Robbins, NL Weintraub, DY Hui, J Rubinstein
PloS one 2013
Assessing the translatability of in vivo cardiotoxicity mechanisms to in vitro models using causal reasoning
AE Enayetallah, D Puppala, D Ziemek, JE Fischer, S Kantesaria, MT Pletcher
BMC Pharmacology and Toxicology 2013
Integrating the myocardial matrix into heart failure recognition and management
FG Spinale, MR Zile
Circulation research 2013
Aberrant differentiation of fibroblast progenitors contributes to fibrosis in the aged murine heart: role of elevated circulating insulin levels
KA Cieslik, JA Trial, S Carlson, GE Taffet, ML Entman
The FASEB Journal 2013
Alpha-tropomyosin mutations in inherited cardiomyopathies
C Redwood, P Robinson
Journal of Muscle Research and Cell Motility 2013
The Notch pathway controls fibrotic and regenerative repair in the adult heart
M Nemir, M Metrich, I Plaisance, M Lepore, S Cruchet, C Berthonneche, A Sarre, F Radtke, T Pedrazzini
European Heart Journal 2012
Genetic Considerations in Hypertrophic Cardiomyopathy
CY Ho
Progress in Cardiovascular Diseases 2012
Hypertrophic cardiomyopathy: Translating cellular cross talk into therapeutics
P Teekakirikul, RF Padera, JG Seidman, CE Seidman
The Journal of Cell Biology 2012
Cytokine mediated tissue fibrosis
LA Borthwick, TA Wynn, AJ Fisher
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 2012
Matricellular Proteins in Cardiac Adaptation and Disease
NG Frangogiannis
Physiological reviews 2012
Coronary Artery Remodeling in a Model of Left Ventricular Pressure Overload Is Influenced by Platelets and Inflammatory Cells
F Yang, A Dong, P Mueller, J Caicedo, AM Sutton, J Odetunde, CJ Barrick, YM Klyachkin, A Abdel-Latif, SS Smyth
PloS one 2012
Epithelial-to-Mesenchymal and Endothelial-to-Mesenchymal Transition: From Cardiovascular Development to Disease
JC Kovacic, N Mercader, M Torres, M Boehm, V Fuster
Circulation 2012
Hypertrophic Cardiomyopathy: A Vicious Cycle Triggered by Sarcomere Mutations and Secondary Disease Hits
PJ Wijnker, V Sequeira, DW Kuster, J van der Velden
Antioxidants & Redox Signaling 2012
The Actin–MRTF–SRF Gene Regulatory Axis and Myofibroblast Differentiation
EM Small
Journal of Cardiovascular Translational Research 2012
Generation of mice with a conditional allele for the transforming growth factor beta3 gene
T Doetschman, T Georgieva, H Li, TD Reed, C Grisham, J Friel, MA Estabrook, C Gard, LP Sanford, M Azhar
genesis 2012
TGFβ-inducible early gene-1 (TIEG1) mutations in hypertrophic cardiomyopathy
JM Bos, M Subramaniam, JR Hawse, I Christiaans, NM Rajamannan, JJ Maleszewski, WD Edwards, AA Wilde, TC Spelsberg, MJ Ackerman
Journal of Cellular Biochemistry 2012
Intrapericardial Delivery of Gelfoam Enables the Targeted Delivery of Periostin Peptide after Myocardial Infarction by Inducing Fibrin Clot Formation
BD Polizzotti, S Arab, B Kühn
PloS one 2012
Identification of Periostin as a Critical Marker of Progression/Reversal of Hypertensive Nephropathy
D Guerrot, JC Dussaule, M Mael-Ainin, YC Xu-Dubois, E Rondeau, C Chatziantoniou, S Placier
PloS one 2012
The adult heart responds to increased workload with physiologic hypertrophy, cardiac stem cell activation, and new myocyte formation
CD Waring, C Vicinanza, A Papalamprou, AJ Smith, S Purushothaman, DF Goldspink, B Nadal-Ginard, D Torella, GM Ellison
European Heart Journal 2012
Thoracic aortic disease in two patients with juvenile polyposis syndrome and SMAD4 mutations
P Teekakirikul, DM Milewicz, DT Miller, RV Lacro, ES Regalado, AM Rosales, DP Ryan, TL Toler, AE Lin
American journal of medical genetics. Part A 2012
Roles of collagen and periostin expression by cranial neural crest cells during soft palate development
K Oka, MJ Honda, E Tsuruga, Y Hatakeyama, K Isokawa, Y Sawa
The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society 2012
Transforming growth factor beta signaling in adult cardiovascular diseases and repair
T Doetschman, JV Barnett, RB Runyan, TD Camenisch, RL Heimark, HL Granzier, SJ Conway, M Azhar
Cell & Tissue Research 2011
New paradigms in hypertrophic cardiomyopathy: Insights from genetics
CY Ho
Progress in Pediatric Cardiology 2011
Identifying Sarcomere Gene Mutations in Hypertrophic Cardiomyopathy: A Personal History
CE Seidman, JG Seidman, J Robbins, H Watkins
Circulation research 2011
Molecular mechanisms underlying cardiac antihypertrophic and antifibrotic effects of natriuretic peptides
C Calvieri, S Rubattu, M Volpe
Journal of Molecular Medicine 2011
Myosin binding protein C: implications for signal-transduction
R Knöll
Journal of Muscle Research and Cell Motility 2011
TGF-β signaling in fibrosis
A Biernacka, M Dobaczewski, NG Frangogiannis
Growth Factors 2011
Mechanisms of disease: hypertrophic cardiomyopathy
N Frey, M Luedde, HA Katus
Nature Reviews Cardiology 2011
Cellular mechanisms of cardiomyopathy
PA Harvey, LA Leinwand
The Journal of Cell Biology 2011
Genetics of sudden cardiac death syndromes
N Chopra, BC Knollmann
Current Opinion in Cardiology 2011
Periostin Is Induced in Glomerular Injury and Expressed de Novo in Interstitial Renal Fibrosis
K Sen, MT Lindenmeyer, A Gaspert, F Eichinger, MA Neusser, M Kretzler, S Segerer, CD Cohen
The American Journal of Pathology 2011
Chronic losartan administration reduces mortality and preserves cardiac but not skeletal muscle function in dystrophic mice
LT Bish, M Yarchoan, MM Sleeper, JA Gazzara, KJ Morine, P Acosta, ER Barton, HL Sweeney
PloS one 2011
Roles of TGF-β Signals in Endothelial-Mesenchymal Transition during Cardiac Fibrosis
Y Yoshimatsu, T Watabe
International Journal of Inflammation 2011
Barcoding bias in high-throughput multiplex sequencing of miRNA
S Alon, F Vigneault, S Eminaga, DC Christodoulou, JG Seidman, GM Church, E Eisenberg
Genome research 2011
Roles for CCN2 in normal physiological processes
F Hall-Glenn, KM Lyons
Cellular and Molecular Life Sciences 2011
Experimental mild renal insufficiency mediates early cardiac apoptosis, fibrosis, and diastolic dysfunction: a kidney-heart connection
FL Martin, PM McKie, A Cataliotti, SJ Sangaralingham, J Korinek, BK Huntley, EA Oehler, GE Harders, T Ichiki, S Mangiafico, KA Nath, MM Redfield, HH Chen, JC Burnett
American Journal of Physiology - Regulatory, Integrative and Comparative Physiology 2011
Phosphoinositide-3 kinase signaling in cardiac hypertrophy and heart failure.
Aoyagi T, Matsui T
Current pharmaceutical design 2011
Genetics and Clinical Destiny: Improving Care in Hypertrophic Cardiomyopathy
CY Ho
Circulation 2010
Pulmonary surfactant: an immunological perspective
ZC Chroneos, Z Sever-Chroneos, VL Shepherd
Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology 2009

← Previous 1 2 3 … 10 11 Next →

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts

Referenced in 4 patents
Referenced in 1 clinical guideline sources
280 readers on Mendeley
See more details